SCHEMBL1968116

SCHEMBL1968116

CCCCOC(=O)N1CC=C(N2CCOCC2)CC1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.59
POLB P06746 2/20 0.59
LMNA P02545 2/20 0.59
MAPT P10636 4/20 0.48
NPC1 O15118 2/20 0.48
RAB9A P51151 2/20 0.48
ALDH1A1 P00352 5/20 0.42
TSHR P16473 4/20 0.41
KMT2A Q03164 4/20 0.39
MEN1 O00255 2/20 0.39
CASP1 P29466 2/20 0.39
RECQL P46063 1/20 0.39
P2RY12 Q9H244 1/20 0.38
THRB P10828 2/20 0.37
L3MBTL1 Q9Y468 2/20 0.36
CYP1A2 P05177 1/20 0.36
CHRM2 P08172 1/20 0.36
CHRM1 P11229 1/20 0.36
HTR2A P28223 1/20 0.36
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11073803 0.81 TSHR (0.51) SMN1; SMN2POLBLMNAMAPTRAB9A
SCHEMBL8259131 0.78 SMN1; SMN2 (0.50) SMN1; SMN2POLBLMNAMAPTNPC1
SCHEMBL797983 0.77 USP2 (0.55) SMN1; SMN2LMNAMAPTALDH1A1KMT2A
SCHEMBL11077865 0.77 TSHR (0.56) SMN1; SMN2POLBLMNAMAPTALDH1A1
SCHEMBL533646 0.77 POLB (0.97) SMN1; SMN2POLBLMNAMAPTNPC1
SCHEMBL11082543 0.76 MAPT (0.42) SMN1; SMN2POLBLMNAMAPTALDH1A1
SCHEMBL3771855 0.76 SMN1; SMN2 (0.47) SMN1; SMN2POLBLMNAMAPTALDH1A1
SCHEMBL11556626 0.76 SMN1; SMN2 (0.48) SMN1; SMN2POLBLMNAMAPTNPC1
SCHEMBL6270709 0.75 SMN1; SMN2 (0.51) SMN1; SMN2POLBLMNAMAPTNPC1
SCHEMBL19880920 0.74 SMN1; SMN2 (0.47) SMN1; SMN2POLBLMNAMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2334676-A1 SUBSTITUTED 3 -AMIN0- 1-0X0 OR THIOXO-I, 2,5,6,7, 8-HEXAHYDR0-2, 7-NAPHTHYRIDINE-4-CARB0NITRILES AS SELECTIVE ALPHA 2B ANTAGONISTS Allergan, Inc. (US) 2011-06-22 EP disclosed